TABLE 2.

Univariate Logistic Regression Model Assessing Seroconversion in Anti‐CD20 Treated Patients

Variable	Univariate analysis
	OR (95% CI)	p	R2
Age	0.97 (0.94–1.00)	0.081	0.031
Sex, female	0.54 (0.16–1.59)	0.287	0.012
Disease, multiple sclerosis	0.85 (0.24–2.59)	0.778	0.001
Disease duration, years	0.99 (0.92–1.07)	0.803	0.001
Months since anti‐CD20 onset	0.99 (0.97–1.00)	0.121	0.024
Months since last anti‐CD20	1.46 (1.20–1.86)	0.001	0.228
Lymphocytes/mcl	1.00 (1.00–1.00)	0.569	0.003

CI = confidential interval; OR = odds ratio; R² = McFadden's R squared.